Background: Different strains of Newcastle disease virus (NDV) worldwide proved to have 39 tumouricidal activity in several types of cancer cells. However, the possible anti-cancer activity of 40
Background 56
To date, cancer remains the tenth leading causes of death worldwide. According to National 57
Cancer Registry Report 2007, breast cancer is the top ranking malignancy that affects Malaysians 58 followed by colorectal cancer [1] . There are a total of 3,292 new cases reported in the year 2007 and 59 contributed 18.1% out of all the types of cancers in Malaysia [1] . However, the number of new cases 60 are slightly less compared with the cases in 2003 (3738 cases reported) [2, 3] and the patient survival 61 rate has also improved. This could be as a result of sensitization campaign, which increases 62 awareness and educates citizen. In addition, early detection, development of advanced medical 63 instruments and surgical techniques, and discovery of various new and effective anti-cancer agents 64 may have resulted in the reduction in the number of cases. 65
There are various types of treatments available for breast cancer patients, including surgery, 66 radiotherapy and chemotherapy. Also, numerous anti-cancer drugs, such as tamoxifen [4], 67
trastuzumab [5] and bevacizumab [6] , have been in the market since their discoveries. However, 68 these drugs show many side effects. For instance, anastrozole that is used for the treatment of breast 69 cancer patients after surgery leads to severe memory impairment [7] and long term use of tamoxifen 70 increases the risk of endometrial cancer [8] . Due to this, tremendous efforts have been made by 71 scientists around the world to explore and develop targeted drug systems with least or no side effects 72 that will specifically target cancer cells without affecting normal healthy cells. 73 Recently, the trend of manipulating a virus to serve as an anti-cancer agent has been increasing [9, 74 10] . Among all types of viruses, oncolytic virus specifically targets cancer cell without causing 75 excessive damage to non-cancerous cells [11] . Numerous oncolytic viruses from different family 76 exhibit different mechanism of tumour selectivity. For instance, herpes simplex virus mutant, G207 77 from herpesviridae family has been used for the treatment of malignant glioma [12] . Mumps virus 78 from the family of paramyxoviridae has been previously used against ovarian cancer [13] , and 79
Sindbis virus from togaviridae family has been proposed as a therapy for cervical and ovarian 80 cancers [14] . 81 Apart from all these viruses, oncolytic Newcastle disease virus (NDV) also has potential as an 82
anti-cancer agent because of its inability to induce immune escape mechanism in mammalian 83 cells [15] . Thus, it may be suitable as an immunologic adjuvant in a human cancer vaccine [16] . NDV 84 belongs to paramyxoviridae family, and causes inflammation of respiratory tract, brain and 85
gastrointestinal tract to poultry [17] . However, it only causes mild flu-like symptoms and 86 conjunctivitis in human [18] . The most common strain that is found in Malaysia is NDV AF2440 87 [19] . It has been reported that NDV AF2240 was capable of stimulating apoptosis in breast cancer 88 cells and the apoptotic effects were correlated with the production of pro-inflammatory cytokines in 89 the tumour cells [20] . These effects are the first steps of immunotherapeutic effects of many crucial 90 cytokines that help in combating breast tumour cells [21] . Several strains of NDV such as 73-T, HUJ, 91 PV701 (MK107), MTH68, and Ulster have been shown to exhibit similar oncolytic properties as that 92
of NDV AF2240 strain. Furthermore, additional exploration of the three Malaysian oncolytic NDV 93 strains, AF2240, F and V4, have also been studied on different types of cancer cell lines in both in 94 vivo and in vitro screening [22] [23] [24] . Of all these strains, only AF2240 (velogenic) was found to be 95 more effective and showed better cytotoxic effect on in vitro MCF-7 cells as compared to the V4-96 UPM (lentogenic) strain [25] . Thus, AF2240 strain has the most significant anti-cancer activity and 97 had proven to be relatively effective in suppressing tumour growth through apoptosis induction [22, 98 26] . Given this, here, we aim to investigate the possible apoptotic mechanism of NDV AF2240 99 against 4T1 breast cancer cells through cytokines induction. 100 101
Results 102

Effect of NDV on body weight and tumour weight in allotransplanted mice 103
All groups of mice showed significant increment in body weight compared with beginning stage 104 (Table 1) . On the other hand, the tumour in all groups increased in size, weight and no signs of 105 regression at the end of the experiment except for groups CNDV8, 16, 32, 64, CNDV8+T and 106
CNDV16+T (Table 1 ). The six groups mentioned above did not show any tumour growth at all. 107
Thus, the percentage of inhibition was up to 100%. In contrast, groups CNDV32+T and CNDV64+T 108 did not show any signs of inhibition, and it seems there is an enhanced tumour growth. CT group 109 which was treated Tamoxifen, a reference drug, showed slightly weak tumour suppression of about 110 16.55%. 111
Liver function test 112
The activity of serum AST, ALT and the level of total bilirubin for all the treated groups are 113
shown in Table 2 . The level of total bilirubin for all groups, except for CNDV32+T and CNDV 64+T 114 groups, showed no significant difference compared with the normal control group. Both treatments 115 indicated a markedly elevated level of total bilirubin. In the case of enzyme activities, cancer control 116 (CC), reference drug (CT), CNDV16 and CNDV64+T significantly increased AST activity. This is 117 especially apparent in the group treated with Tamoxifen (CT), which showed an increase one-fold 118 higher than the normal control. On the other hand, groups CT, CNDV8+T, CNDV32+T and 119
CNDV64+T showed a significant increment of ALT activity as compared to normal control. 120 
Groups/Week
Week 1 26.0 ± 1.4 b 87.5 ± 0.7 91.5 ± 0.7 b 101.5 ± 0.7 
Week 1 Week 2 Week 3 Week 4 
Week 1 Week 2 Week 3 Week 4 NC 1.0 ± 0.0 1.0 ± 0.0 1.0 ± 0.0 1.0 ± 0.0 CC 21.5 ± 12.0 a 29.5 ± 9.2 a 37.5 ± 7.8 a 56.5 ± 14.9 a CT 24.5 ± 10.6 27.0 ± 8.5
9.5 ± 4.9 b 13.5 ± 4.9 b 18.5 ± 12.0 b 12.0 ± 4.2 b 203 
Week 1 CNDV32+T 11.5 ± 3.5 12.5 ± 4.9 b 14.5 ± 4.9 b 15.5 ± 2.1 b CNDV64+T 11.5 ± 2.1 12.5 ± 3.5 b 21.0 ± 1.4 b 21.0 ± 5.7 b [27]. Embryonated chicken eggs aged 9 to 10 days were obtained from Linggi Poultry Farm, Negeri 237
Sembilan, Malaysia. Upon arrival, the eggs were sprayed with 70% ethanol and wiped thoroughly 238
with tissue paper to prevent contamination. The eggs were then kept in a 37 o C-humidified incubator 239
for 24 hours. The embryos were candled daily to monitor its viability. Same method was also used to 240 determine the margin of air sac of the embryos, which were marked with a pencil prior to inoculation 241 of the virus. All procedures were carried out under biological safety cabinet to minimise any 242 contamination. 243
Seed Virus Dilution 244
Preparation of seed virus depends on the number of eggs used. Briefly, 10 fold of virus dilutions 245 were prepared. First, three centrifuge tubes were filled with 9 ml of phosphate buffer saline (PBS) 246 and the subsequent tubes were filled with 27 ml PBS. Approximately 1 ml of virus was filtered using 247 0.45 µM filter and added to the first centrifuge tube containing 9 ml PBS and suspended for several 248 times to get 1 in 10 dilutions of the virus. By using a syringe, approximately 1 ml of the dilution was 249 transferred to the second centrifuge tube before being suspended several times. This process was 250 repeated until the third centrifuge tube. Finally, 3 ml of dilution from the third centrifuge tube was 251 transferred to the fourth centrifuge tube containing 27 ml PBS to obtain a dilution of 10 -4 NDV 252
AF2240 which was used for the inoculation of virus in the embryonated chicken eggs. 253
Virus Inoculation 254
Virus was inoculated in eggs per method used by Alexander [28] with slight modification. A small 255 hole approximately 1 mm in diameter was made using a sterile needle right above the air sac margin. 256
By using a syringe, 0.1 ml of virus dilution was inoculated into each egg. Then the eggs were 257 sterilised using 70% ethanol before using melted candle or sterile tape to seal the hole. The eggs were 258 then kept inside the incubator and checked for dead embryos using candling after 48 hours. The eggs, 259 which found to have dead embryos were removed and kept in the refrigerator at 4 o C. The eggs were 260 monitored daily for 96 hours or until 90% of the embryos died. All the eggs were kept in the 261 refrigerator overnight to ensure that the blood vessel is constricted before virus harvesting process. 262
This can avoid collection of blood during harvesting of the allantoic fluid. 263
Virus Harvesting 265
The eggs were left under a biological safety cabinet at room temperature for 30 minutes to avoid 266 excessive condensation on the shells once removed from the refrigerator. The eggs shells above the 267 air sac were then removed and the membranes were punctured to collect the allantoic fluid. If there 268
were any visible contamination, the eggs were immediately rejected. To confirm the presence of 269 NDV in the allantoic fluid, a rapid test using chicken red blood cells was conducted. The allantoic 270 fluids collected were kept in sterile tubes. Immediately after all the allantoic fluids were harvested, 271
the clarification and purification of the virus was carried out. 272
Virus Clarification and Purification 273
In brief, the clarification of allantoic fluid was done at 6000 g, 4 o C for 10 minutes by using a 274 refrigerated centrifuge. The supernatants were then centrifuged at 20,000 rpm, 4 o C for 3 hours. 275
Again, the supernatant was discarded while the pellet was re-suspended and dissolved in 1 ml NTE 276 buffer (NaCl, Tri-HCl, EDTA). In addition, 30%, 40%, 50% and 60% of sucrose gradients were 277 prepared in ultra-clear tubes and kept overnight at 4 o C. A few drops of virus in NTE buffer were 278
added to the sucrose solution by using a sterile pipette until all the tubes were equally balanced. The 279 tubes were then centrifuged at 38,000 rpm, 4 o C for 4 hours by using pre-cooled SW41 rotor. After 280 the centrifugation, observation and marking of the purified band of virus was made under inverted 281 microscope. The band was collected and transferred into polyalomer tubes. The tubes were topped-up 282
with NTE buffer and balanced before subjected to centrifugation at 20,000 rpm at 4 o C for 2 hours. 283
The pellets obtained were dissolved in 1 ml NTE buffer and filtered using 0.4 µm filter. Finally, the 284 suspensions were kept at -80 o C until further use. 285
Preparation of Chicken Red Blood Cells for Virus Titration 286
Blood was withdrawn from the jugular vein of chicken by using syringe that filled with a mixture 287 of PBS and EDTA to prevent the blood from clotting. The blood was transferred into 15 ml tube and 288 topped-up with PBS, then centrifuged at 1000 rpm at room temperature for 10 minutes. The 289 supernatant was discarded and the red blood cells were re-suspended in PBS and centrifuged again. 290
This process was repeated for 3 more times. For virus titration purpose, 50 µl of the RBC was diluted 291 in 100 ml PBS to get 0.5% suspension of RBC cell in PBS. 292
Haemagglutination (HA) Test 293
For HA test, 2 nd to 24 th well of 96-well plate were filled up with 50 µl of PBS while the 1 st well 294 was filled up with 100 µl of purified virus. 50 µl of purified virus was transferred from the 1 st well 295
into the 2 nd well to make a two-fold dilution and this continued until the 23 rd well. Then, 50 µl of the 296 0.5% RBC suspension was added into all wells and left for 30 minutes at room temperature. The 1 st 297 well was served as positive control whereas the 24 th well served as negative control. Any appearance 298 of red button was observed in all wells except the 24 th well that represented the virus HA titre. 299
NDV titre for Treatment 300
Viruses were prepared from titre of 10 8 where it was neatly harvested from chicken eggs. Then the 301 viruses were diluted to 8 HA, 16 HA, 32 HA and 64 HA unit of NDV as described in the serum and 1% penicillin/streptomycin. Cells were maintained at 37 o C in a humidified atmosphere of 315 5% CO 2 in air. Culture medium was replaced every 2 to 3 days until the cell become 90% confluence 316 before being subculture or used in the further experiment. For cancer cell induction purpose, the cell 317 concentration was adjusted to 1 x 10 4 cells/ml (0.1 cc injection per mice). 318
Animals 319
Healthy BALB/c mice weighing 15 -20 g of age between 6 -7 weeks old were obtained from 320
Institute of Medical Research (IMR, Malaysia). The animals were reared in the animal house of 321
Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, where they were kept in plastic 322 cages under hygienic conditions and were provided with standard animal feed. All the animal works 323
were conducted in accordance with institutional guidelines for Animal Care and Use Committee 324 (ACUC), Faculty of Medicine and Health Sciences, Universiti Putra Malaysia. 325
Experimental Design 326
Total 90 mice were used in this study and they divided into 15 groups (10 allotransplanted and 5 327 normal) with each group consisted of 6 mice. The normal category comprised of 5 groups of mice 328 that were treated with 8, 16, 32 and 64 HA NDV without xenotransplant of cancer cells (NDV), 329
while, a group that is only treated with normal feeding (without NDV and cancer cells) was served as 330 control (NC). On the other hand, another 10 groups were allotransplanted with 4T1 breast cancer 331 cells, which are under xenotransplantation category. Out of 10 groups, 4 groups were received 0.1 cc 332 of 0.5 µg/ml Tamoxifen in combination with 8, 16, 32 and 64 HA of NDV, respectively (CNDV+T); 333 another 4 groups were treated with 0.1 cc of 8, 16, 32 and 64 HA of NDV only (CNDV), 334 respectively. A group of allotransplanted mice without subjected to any virus or tamoxifen was 335 served as cancer control (CC), while, another group was only treated with 0.1 cc of 0.5 µg/ml 336 tamoxifen was served as positive control (CT). 337 338
Tumour, Body Weight and Mortality
The body weight and tumour weight of the mice were measured on the first and last day after 340 inoculation with NDV and allotransplanted with 4T1 breast cancer cells. The mortality rate of the 341 mice for each group was also assessed every day until day 28 to determine the effect of NDV, 342
NDV+Tamoxifen on the survival rate of mice. 343
Analysis of Liver Function 344
For assessment of liver function, plasma enzyme activities of total bilirubin level, alanine 345 aminotransferase (ALT) and aspartate aminotransferase (AST) were determined using an automated 346 procedure. 347
Cytokine Determination by Cytometric Bead Array (CBA) 348
Measurement of interleukin-6 (IL-6), interleukin-10 (IL-10), interleukin-12p70 (IL-12p70), 349
interferon-γ (IFN-γ), monocyte chemoattractant protein-1 (MCP-1) and tumour necrosis factor-α 350
(TNF-α) were performed using a mouse inflammation cytometric bead array kit (CBA; BD 351
Biosciences, Malaysia). The assay protocol was done strictly according to the manufacturer's 352 instructions and the samples were analyzed with flow cytometer incorporated BD FACSComp TM 353 software. 354
Determination of Cytokines by Enzyme-Linked Immunosorbent Spot (ELISPOT) 355
Spleen cells suspension was prepared according to the method by Yang et al. [29] with slight 356 modified. Spleen was removed and placed in plates containing Hank's balanced salt solution (HBSS)  357 under sterile techniques. Spleen was then cut into small pieces and mashed through a nylon sieve. 358
Clumps and debris were removed by allowing them to settle down before the cell suspension was 359 transferred to clean centrifuge tube. Cell suspension was then centrifuged at 200 g, 4 o C for 15 360 minutes. Supernatant was discarded and cells were gently re-suspended with red cell lysing buffer in 361 order to lyse erythrocytes. Again, the cell suspension was centrifuged at 200 g, 4 o C for 5 minutes to 362 remove cell debris and ghosts. After 2 washing in cold HBSS, the mononuclear cells were counted by 363 trypan blue exclusion. Cell concentration was adjusted to the 1.5 to 3.0 x 10 5 cells/ml in cell culture 364 medium and kept on ice until further use. The ELISPOT assays were conducted by using the IL-6, 365 IL-10, MCP-1, TNF-α, IFN-γ and IL-12p70 ELISPOT kit (BD Biosciences, Malaysia) according to 366 the manufacturer's protocol. Samples were run in quadruplicates. Virotherapy has emerged as a novel and potential anticancer agent in recent years. Numerous 378 viruses were found to possess anti-cancer properties, especially oncolytic viruses [30] [31] [32] [33] . Due to its 379 unique mechanism of action and its ability to impact on many types of human cancer, NDV has been 380
proposed as a potent cancer agent. Many strains of NDV were found to exhibit anti-cancer activity, 381
for instance, MTH-68/H and AF2240 exhibited its anti-tumour effect via induction of nitric oxide 382 synthesis from macrophages [34, 35] . In addition, systemic therapy with NDV strain PV701 showed a 383 promising result as an important therapy for patients with a solid tumour [36] . Apart from that, other 384 strains of NDV that have been investigated are HUJ [37] , 73-T [38], V4UPM [39] and AF2240 [40] . 385
There are two strains of NDV that can be found commonly in Malaysia, namely AF2240 and V4-386 UPM. In our previous studies, exposure of NDV AF2240 showed an apoptotic effect against breast 387 tumour cells [23, 41] . However, the underlying mechanism of action on how NDV AF2240 kills the 388 breast cancer cells remains largely unclear. In order to understand the mechanism of action, the 389 current study aimed to evaluate the serological effects of NDV AF2240 inoculation in enhancing 390 breast tumour by inhibiting cytokines secretion by the host immune system. In addition, the effect of 391 NDV AF2240 on the liver was evaluated using liver function test throughout. 392
Based on in vivo pilot study conducted prior to this experiment, the minimum effective dosage 393 required to suppress tumour cell by NDV AF2240 was 8HA (data not shown). Therefore, the dosage 394 that was used in the current study started from 8HA up to 64HA. Due to this, the effect of high 395 concentration of NDV AF2240 on body weight and mortality rate were investigated throughout the 396 experiment. Interestingly, the results of the present study indicated that the NDV AF2240 was 397 tolerated in mice even at 64HA. In addition, there were no significant adverse physical changes 398 observed in the body weight and food intake of mice in the treated groups as compared to control 399 group. Several studies reported that pre-and post-operative cancer patients show weight loss or 400 cachexia [42, 43] . However, the overall body weight increased over time in the present study. Thus, it 401
is suggested that the main contributor for weight increment was due to the tumour itself. In the case 402 of tumour growth profile, tumour growth in all transplanted 4T1 breast cancer cells groups was 403 completely inhibited by treatment with NDV alone. Conversely, low concentration of 404
NDV+Tamoxifen (8 and 16HA) completely suppressed tumour growth, while at high concentrations 405
(32 and 64HA), enhanced tumour cell growth was observed. Therefore, it is believed that there may 406 have been some antagonistic effect between high titres of NDV with tamoxifen, neither allowing 407 NDV nor tamoxifen to execute its effect in killing 4T1 tumour cells. 408
In order to evaluate the hepatotoxicity caused by the NDV as well as a combination of NDV and 409 tamoxifen, liver biochemical parameters such as total bilirubin, AST and ALT were determined. 410
Plasma concentrations of bilirubin, ALT and AST can be used as good indicators of the functionality 411 and cellular integrity of the liver [44] . In addition, they are also good biomarkers that are used to 412 predict any possible toxicity [45] . The present study demonstrated a significant elevation of bilirubin; 413
AST and ALT in CNDV+T (32 and 64 HA) group compared to normal control. Moreover, the group 414 treated with tamoxifen alone also showed significant increment in AST and ALT. This suggests that 415 the high titre of NDV with tamoxifen or tamoxifen may cause damage to hepatocytes. Indeed, several 416 studies revealed that that tamoxifen might cause toxic hepatitis, cirrhosis and sub massive hepatic 417 necrosis [46, 47] . In terms of liver function enzymes, ALT is a more specific indicator of liver 418 function, as compared to AST, which can also be found in red blood cells, cardiac and skeletal 419 muscle [48] . Increased level of bilirubin may also indicate liver disease, biliary stricture, cardiac 420 problem and neonatal hyperbilirubinaemia [49] . Therefore, careful consideration in interpreting the 421 bilirubin level, ALT and AST enzyme activity has to be made with regards to findings from this 422 study. Moreover, many factors can contribute to the elevation of the parameters observed here. 423
The current study showed that inoculation of NDV AF2240 could be beneficial for the treatment 424 of breast cancer, but little is known about its mechanism of action. In order to elucidate a possible 425 mechanism for the anti-neoplastic activity of NDV, immunological effects induced by NDV AF2240 426 was evaluated by determining the following cytokines; IL-6, IL-10, IL-12p70, IFN-γ, TNF-α and 427 MCP-1. All the cytokines were measured by using ELISPOT and cytometric bead array assay. breast cancer bearing mice challenged with a combination of NDV Af2240 and tamoxifen. Although 448 the result for cancer control is higher in CBA assay compared with ELISPOT, this may be that the 449 cytokine-producing cell measurements done by using ELISPOT did not account for productivity per 450 individual cells. Thus, it does not allow the differentiation on whether few cells produce many 451 cytokines or many cells produce little cytokines as shown by CBA assay. 452 IL-12 is capable of evoking a potent immune response and also down-regulates the formation of 453 new blood vessels into growing tumour [62] . IFN-γ is known as the key downstream factor induced 454 by IL-12. Thus, the antitumour activity exerted by IL-12 is believed largely to be due to the local 455 IFN-γ production and subsequent activation of the angiostatic chemokines IP-10 [63] . Nastala and 456 her colleagues [64] reported that the tumour regression induced by recombinant IL-12 is associated 457 with the production of IFN-γ. Hence, IL-12 therapy is crucial for cell-mediated-antitumour activity. 458
However, results from this study revealed that treatment with NDV or NDV+Tamoxifen induces 459 sustained low concentration of IL-12 and IFN-γ in breast cancer-bearing mice. This finding could 460
suggest that NDV induces tumour regression via other signalling molecules or cytokines, but not IL-461 12 -IFN-γ pathway. 462 IL-10 is known to play an important role in inflammation. It suppresses the activation of 463 macrophages and dendritic cells. In addition, it also inhibits numerous innate immune response and is 464 associated with inflammatory activities [65] . On the other hand, high secretion of IL-10 has been 465 found in various types of cancer cell, including breast, kidney, colon, lung and pancreas cancer [66-466 69] . In the context of breast cancer, IL-10 may act as a two-edged sword. Elevation of IL-10 level 467 could facilitate the development of cancer by supporting tumour cell escape from host immune 468 response via activation of PRL-R variants with altered pro-inflammatory or abrogated function. On 469 the other hand, IL-10 could also prevent or reduce tumour growth and metastasis via suppression of 470 angiogenesis [70] . Current results showed that cancer control (CC) group expressed a high level of 471 IL-10, and this is similar to the studies done by Kozlowski et al. [71] and Razmkhah et al. [72] . 472
Interestingly, breast cancer-bearing mice treated with a combination of NDV and tamoxifen showed 473 a reduction in IL-10. Hence, it could be suggested that NDV+tamoxifen exhibited a synergistic 474 effect, which prevents cancer growth through suppression of IL-10 secretion. 475
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